Heart infection treatment gets smarter: new study aims to tailor antibiotic doses

NCT ID NCT04647331

Recruiting now Knowledge-focused Sponsor: Uppsala University Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 20, 2026 · Updated 17 times

Summary

This study looks at how the body processes antibiotics in 150 people with a serious heart infection called endocarditis. Researchers will measure drug levels in the blood and use that data to create a model that predicts the best dose for each patient. The goal is to make sure everyone gets enough antibiotic to fight the infection without getting too much, which can cause side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Karolinska University Hospital
NOT_YET_RECRUITING

Stockholm, Sweden

Contact Email: •••••@•••••
Sahlgrenska University Hospital
ACTIVE_NOT_RECRUITING

Gothenburg, Sweden
Skåne University Hospital
RECRUITING

Lund, Sweden

Contact Email: •••••@•••••
Uppsala University Hospital
RECRUITING

Uppsala, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

INFECTIVE ENDOCARDITIS